Navigation Links
Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
Date:8/6/2009

ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the quarter ended June 30, 2009, on Monday, August 10, 2009, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at 10:00 AM ET on Monday, August 10, 2009. Also participating on the call will be Stephanie R. Irish, Acting CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.

    The teleconference dial-in numbers are as follows:
    Domestic callers 1-800-599-9829
    International callers 1-617-847-8703
    Participant Passcode 93125446

The conference call will be broadcast simultaneously and archived on the Company's Web site, www.vandapharma.com. Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Monday, August 10, beginning at 1:00 PM ET and will be accessible until Monday, August 17, 2009, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 78449791.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
2. Vanda Pharmaceuticals Reports First Quarter 2009 Results
3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
4. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
7. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
8. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
9. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
10. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
11. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... NY (PRWEB) May 17, 2013 ... Topical BioMedics, Inc., has been listed among nationally ... in an initiative conducted by "U.S. News" Health ... has earned the “No. 1 Pharmacists Recommended ... 17 other national OTC brands, and is the ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Dr. Sparano ... and Women’s Health at the Albert Einstein College of ... at the Montefiore Medical Center. He is also ... Center and leads the Einstein Breast Cancer Working Group, ... translational breast cancer research. He also serves as Vice ...
(Date:5/17/2013)... May 17, 2013 Oven Industries Inc. ... The 5R6-900 temperature controller has many user-friendly benefits. Contained ... into the wall as a self-contained temperature control ... distinctive detail makes the device unique, as well as ... can also be used universally, which allows the user ...
(Date:5/17/2013)... the transplant recipient,s immune system identifies the transplanted organ ... thought that T cells, the immune cells that mediate ... chemokines in order to migrate to the transplanted organ. ... Investigation , Fadi Lakkis and colleagues at the University ... of T cells is not required for migration. Instead, ...
Breaking Biology Technology:Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3New Temperature Control Products Announced by Oven Industries Inc. 2
... Inc. (FEED), one of the largest independent hog production ... entry into a genetics program arrangement with Hypor, a ... leading provider of superior swine genetics and technology. Hypor ... be one of the world,s largest broad-based breeding pyramids ...
... peer-reviewed research journal, is partnering with Applied Biosystems, a division of ... Genomics to be broadcast live online at 12 noon ET (4:00 ... ... 2009 -- The business office of Science, the world,s leading peer-reviewed ...
... Stemedica Cell Technologies, Inc., a leader in adult stem cell research ... joined Stemedica,s Scientific Advisory Board. In this capacity, she will ... bio-processing and cellular delivery system for burn and wound management. ... ...
Cached Biology Technology:AgFeed Industries Enters Into Hog Genetic Program Arrangement with Hypor, the Pig Breeding Division of Hendrix Genetics B.V. 2AgFeed Industries Enters Into Hog Genetic Program Arrangement with Hypor, the Pig Breeding Division of Hendrix Genetics B.V. 3AgFeed Industries Enters Into Hog Genetic Program Arrangement with Hypor, the Pig Breeding Division of Hendrix Genetics B.V. 4Science Magazine to Host Webinar on Advances in Cancer Genomics 2Science Magazine to Host Webinar on Advances in Cancer Genomics 3Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 2Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 3Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 4
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...
(Date:5/18/2013)... (May 18, 2013) An increasing number of ... interventions to resolve, according to research presented at ... study targeting obesity, researchers at the Cleveland Clinic ... unique pattern of exhaled breath compared to their ... organic compound levels that can be correlated to ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3
... N.J., Oct. 26 BIO-key International, Inc. (OTC Bulletin ... is showcasing donor and patient identity solutions at the ... Convention Center from October 25-27 2009. BIO-key will provide ... booth #424. Also, at 5 PM on Monday, October ...
... University physical scientists will partner with researchers at ... behind the evolution of cancer under a five-year, ... The Princeton Physical Sciences-Oncology Center was launched ... the institute,s new network of Physical Sciences-Oncology Centers. ...
... research collaboration led by biologists and neuroscientists at the University ... that is the cause of cognitive impairment due to sleep ... cognitive deficits caused by sleep deprivation, such as an inability ... the concentration of a specific enzyme that builds up in ...
Cached Biology News:BIO-key(R) International Exhibiting at AABB TXPO 2NCI awards $15.2 million to create Princeton Physical Sciences -- Oncology Center 2NCI awards $15.2 million to create Princeton Physical Sciences -- Oncology Center 3NCI awards $15.2 million to create Princeton Physical Sciences -- Oncology Center 4Fighting sleep, Penn researchers reverse the cognitive impairment caused by sleep deprivation 2
... coli RY 13 5'G AATTC3' 3'CTTAA G5' Inactivation ... or ethanol precipitation. Storage Conditions: 10mM Tris-HCl (pH ... Triton X-100, 0.01% BSA, 50% glycerol. Shipping and ... Unit Definition: One unit is defined as the ...
... Bacillus globigii 5'GCCNNNN NGGC3' 3'CGGN NNNNCCG5' Inactivation ... min or phenol treatment followed by ethanol ... 200mM KCl, 0.1mM EDTA, 1.0mM DTT, 0.01% ... on dry ice. Store at -20C. Unit ...
...
RABBIT ANTI HUMAN ALPHA-2-ANTIPLASMIN...
Biology Products: